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Table 1. Left ventricular function according to the fragmentation seen
Fragmentation(-) Fragmentation(+)
MeanSD(Median) MeanSD(Median) p
Ejection fraction (%) 50.2110.47 (50) 41.6611.45 (40) 0.001**
Left ventricular systolic
diameter
3.190.59 (3.2) 3.670.79 (3.6) 0.001**
Left ventricular diastolic
diameter
4.870.42 (4.9) 5.170.61 (5.2) 0.001**
Student t Test, ++Mann Whitney UTest **p<0.01
Table 2. Exchange of Left Ventricular EF According to Number of fQRS
Derivations
Number of
fragmented
Derivations 0 2 3 4
MeanSD MeanSD MeanSD MeanSD p
LVEF (%) 49.9310.48 43.8410.90 42.7911.23 38.5411.84 0.001**
One Way Anova Test **p<0.01
Table 1. Clinical and spirometric characteristics of the subjects
Patients with COPD
(n ¼ 43)
Controls
(n ¼ 50) P value
Age, years 60.59.9 59.67.1 0.82
Females n (%)
Males n(%)
2 (5)
41 (95)
6 (12)
43 (88)
0.28
BMI, kg/m2 26.74.6 27.03.9 0.68
BSA, m2 1.880.20 1.910.15 0.37
Smoking status,
n (%)
38 (88) 11 (22) <0.001
SBP, mmHg 122.210.7 122.48.9 0.92
DBP, mmHg 75.47.5 75.07.1 0.77
Heart rate,
beats/min
74.513.6 69.610.2 0.048
FEV1, (%) 64.621.3 99.813.9 <0.001
FEV1-FVC ratio 59.410.1 79.15.2 <0.001
COPD, chronic obstructive pulmonary disease; BMI, body mass index; BSA, body surface area;
SBP, systolic blood pressure; DBP, diastolic blood pressure; FEV1, forced expiratory volume in
the ﬁrst second; FVC, forced vital capacity.
Table 2. Intergroup comparison of echocardiographic parameters
COPD patients
(n¼43)
Controls
(n¼50) P value
LV end-diastolic
diameter, mm
47.64.2 48.63.5 0.23
LV ejection
fraction, (%)
65.72.7 66.43.1 0.23
LV mass
index, g/m2
88.915.4 93.416.7 0.18
Left atrial
dimension, mm
35.23.9 36.13.6 0.22
Left atrial volume
index, ml/m2
19.96.7 24.99.9 0.006
Right atrial
area, cm2
15.06.5 14.42.9 0.58
Right ventricle
basal, mm
36.55.0 36.54.0 0.96
Right ventricular
fractional
area change, (%)
425.4 46.36.1 0.08
TAPSE, cm 2.10.3 2.20.2 0.34
sPAP, mmHg 27.98.9 23.03.3 0.001
Conventional Doppler
Mitral E/A 0.880.27 1.010.25 0.02
Tricuspid E/A 1.000.23 1.190.20 0.001
Tissue Doppler
Lateral Em/Am 0.830.3 0.870.3 0.49
Lateral MPI 47.59 46.17 0.38
Septum Em/Am 0.710.2 0.690.2 0.60
Septum MPI 50.711.2 51.98.5 0.19
Tricuspid Em/Am 0.630.2 0.680.2 0.24
Tricuspid MPI 51.99.7 46.17.9 0.002
COPD, chronic obstructive pulmonary disease; LV, left ventricle; TAPSE, tricuspid annular plane
systolic excursion; sPAP, systolic pulmonary artery pressure;MPI,myocardial performance index.
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Objective: The aim of this study was to evaluate atrial electromechanical delay,
inﬂammation, and oxidative stress parameters, and was to investigate clinical and
laboratory characteristics affecting atrial electromechanical delay in patients with
chronic obstructive pulmonary disease (COPD).
Methods: Forty-three patients with COPD (60.59.9 years) and 50 healthy controls
(59.67.1 years) were included. Using tissue Doppler imaging (TDI), atrial electro-
mechanical delay intervals were measured from lateral mitral annulus (cPA lateral)
and lateral tricuspid annulus (cPA tricuspid), and corrected for heart rate. Left and
right ventricles functions were examined using conventional and TDI. Plasma levels
of high sensitive C-reactive protein (hsCRP) and oxidative stress parameters were
measured. Factors associated with atrial electromechanical delay were evaluated by
stepwise multiple regression analysis.
Results: Clinical characteristics and spirometric ﬁndings for the two groups are
presented in Table 1. Age, sex, body mass index, body surface area, and systolic and
diastolic blood pressure are similar between the groups (p>0.05). Smoking status and
heart rate at rest are signiﬁcantly higher in patients with COPD compared to the
controls (p<0.05). Conventional and tissue Doppler echocardiographic parameters
for the groups are shown in Table 2. Left atrium volume index, sPAP, mitral E/A
ratio, and right ventricle myocardial performance index differ signiﬁcantly between
the groups (p<0.05). Measurements of atrial electromechanical delay, oxidative
stress, and inﬂammation markers between COPD patients and controls are
presented in Table 3. cPA lateral, cPA septum, and cPA tricuspid are signiﬁcantly
higher in patients with COPD compared to controls (p<0.05). Also, hsCRP and
malondialdehide are signiﬁcantly higher in patients with COPD (p<0.05). cPA
lateral is independently related to lateral Em/Am ratio (b¼-0.29, p¼0.004) and
FEV1/FVC ratio (b¼-0.24, p¼0.02). cPA tricuspid is independently related only to
FEV1/FVC ratio (b¼-0.51, p<0.001).
Conclusions: This study shows that atrial electromechanical delay intervals are pro-
longed in patients with COPD. Prolongation of atrial electromechanical delay may be
related with inﬂammation, oxidative stress, and FEV1/FVC ratio in these patients.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS C9
Table 3. Intergroup comparison of atrial conduction times, oxidative stress
and inﬂammation markers
Patients (n¼43) Controls (n¼50) P value
cPA lateral, ms 69.810.4 62.28.9 <0.001
cPA septal, ms 50.07.5 40.96.2 <0.001
cPA tricuspid, ms 45.410.2 33.55.1 <0.001
Glutathione peroxidase, U/gHb 1.931.50 2.041.91 0.77
Superoxide dismutase, U/gHb 8677.55574.0 9267.75538.5 0.61
Catalase, U/gHb 7.89.4 8.08.7 0.91
Malondialdehyde, nmol/l 17.110.3 11.67.9 0.005
hsCRP, mg/l 15.731.7 4.84.7 0.01
cPA, corrected atrial electromechanical delay (time interval from the onset of P wave on
surface ECG to the beginning of A wave interval with tissue Doppler imaging); hsCRP, high
sensitive C-reactive protein.
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Background: Glutathione S transferases (GSTs) are enzymes responsible for the
metabolism of numerous xenobiotics and are known to be polymorphic in humans.
Glutathione S-transferases (GSTs) detoxify environmental agents which inﬂuence the
onset and progression of disease. Carcinogenic and toxic molecules produce DNA
adducts that contribute to the development of atherosclerosis. Genetic polymorphisms
of xenobiotic-detoxiﬁed enzymes, which control the level of DNA adducts, may affect
both enzymatic activity and individual susceptibility to coronary artery disease
(CAD). Dysfunctional detoxiﬁcation enzymes are responsible for prolonged exposure
to reactive molecules and can contribute to endothelial damage, an underlying factor
in CAD. Coronary artery ectasia (CAE) is deﬁned as local or generalized aneurysmal
dilatation of the coronary arteries. Although the etiology of CAE has not been iden-
tiﬁed completely, the most frequent cause is coronary atherosclerosis. Endothelial
dysfunction and enzymatic destruction of media layer plays an important role in the
pathogenesis of coronary ectasia. We aimed to examine the association between
GSTM1, T1 gene polymorphisms and CAE.
Methods: Our studywas carried out in a total of 90 cases diagnosedwithCAEand a total
of 91 population-matched healthy controls in respect to age and genders. After DNA
isolation, polymorphisms were analyze using Polymerase Chain Reaction-Restriction
Fragment Length Polymorphism (PCR-RFLP)methods. Distribution of theGSTM1and
GSTT1 polymorphism genotypes were determinated asWild (*1*/1) genotype (Normal
genotype) and null (*0*/0) genotype (homozygous deletion). In our study CAE group
was also divided into subgroups in respect to herbicide exposure.
Results: No signiﬁcant differences were obtained in terms of age, genders, risk
factors, biochemical parameters and echocardiographic characteristics between study
and control groups. The levels of GSTM1 and T1 polymorphisms were statistically
higher in CAE cases than controls (p<0,05). Genotype distribution and the levels of
GST enzymes of CAE and control groups shown in the table. GSTM1 and T1
homozygous mutations were detected signiﬁcantly higher in those with exposure to
herbicides in patients with coronary artery ectasia group.
Conclusions: To our knowledge this is the ﬁrst study examining the polymorphisms
encoding GST enzymes polymorphisms in cases with CAE. Our results suggest that
the deletions in GST genes associated with patients CAE. We think the data obtained
in this study can be used to direct people who have deletions in GST genes to avoid
chemicals and herbicide exposure.C10 JACC VOP-027
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Introduction: Coronary artery ectasia (CAE) is localized or diffuse swelling of
epicardial coronary arteries 1.5 times the diameter of the adjacent normal coronary
segment. Atherosclerosis, congenital causes, inﬂammatory or connective tissue
disorders are among the probable etiologies however exact etiology remains
unclear. In some studies, CAE was shown to be a generalized disease affecting
other vascular beds. Microalbuminuria is the subclinical increase in urinary
albumin which is 30-300 mg/day in a spot urine check and is related to increased
morbidity and mortality in cardiovascular disease. The aim of our study is to ﬁnd
out the relationship between levels of urinary microalbumin and isolated coronary
artery ectasia.
Methods: 58 patients with isolated CAE and 57 control subjects with normal
coronary arteries (NCA) were included in the study. Previous history of myocardial
infarction and percutaneous intervention, left ventricular hypertrophy, left ventric-
ular dysfunction (EF <50%), moderate-severe valvular disease, rhythms other than
sinus, congenital heart disease, chronic obstructive lung disease and/or cor pulmo-
nale, chronic systemic illness, active infection, renal failure, neoplastic disease,
antioxidant drug usage and alcohol abuse were the exclusion criteria. Midstream
random urine samples were collected in the morning and microalbuminuria was
determined by immunoturbidimetric method. The results were given as albumin /
creatinine ratio (mg/mg). The values between 0.03 and 0.3 were deﬁned as
microalbuminuria.
Results: The mean age was 60,559,77 in CAE and 57,328,30 in NCA group-
s,respectively. There was not any statistically signiﬁcant difference between groups
according to the cardiovascular risk factors like gender, hypertension, smoking,
hyperlipidemia, diabetes mellitus and family history of CAD and the drugs used.
Urinary albumin to creatinine ratio was 0,0360,040 in isolated CAE and
0,0180,013 in the control group, respectively, and the difference was statistically
signiﬁcant (p¼0.002).
Conclusions: Microalbuminuria is a well established risk factor for cardiovascular
morbidity and mortality. In our study we showed that urinary microalbumin levelsol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
